Vitrectomy for primary symptomatic vitreous opacities: An evidence-based review

Eye (Basingstoke)

Volumn 30, Issue 5, 2016, Pages 645-655

  Ivanova, T ^a   Jalil, A ^a   Antoniou, Y ^a   Bishop, P N ^a,b   Vallejo Garcia, J L ^a,c   Patton, N ^a  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEEP ANTERIOR VITRECTOMY; EVIDENCE BASED PRACTICE; HUMAN; INCIDENCE; LOW LEVEL LASER THERAPY; NEODYMIUM YAG LASER; PARS PLANA VITRECTOMY; PATHOGENESIS; PATIENT SAFETY; PHACOEMULSIFICATION; PREVALENCE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SYMPTOMATIC VITREOUS OPACITY; THERAPY EFFECT; VISION; VITRECTOMY; VITREOLYSIS; VITREOUS BODY; VITREOUS BODY DETACHMENT; VITREOUS FLOATERS; VITREOUS OPACITY; EVIDENCE BASED MEDICINE; EYE DISEASES; PATHOLOGY; PSYCHOLOGY;

EVIDENCE-BASED MEDICINE; EYE DISEASES; HUMANS; QUALITY OF LIFE; VITRECTOMY; VITREOUS BODY;

EID: 84971669209     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2016.30     Document Type: Review

References (52)

1. Wagle AM, Lim WY, Yap TP, Neelam K, Au Eong KG. Utility values associated with vitreous floaters. Am J Ophthalmol 2011; 152: 60-65
2. Schiff WM, Chang S, Mandava N, Barile GR. Pars plana vitrectomy for persistent, visually significant vitreous opacities. Retina 2000; 20: 591-596
3. Vandorselaer T, Van De Velde F, Tassignon MJ. Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters. Bull Soc Belge Ophtalmol 2001; (280): 15-19
4. Mossa F, Delaney YM, Rosen PH, Rahman R. Floaterectomy: combined phacoemulsification and deep anterior vitrectomy. J Cataract Refract Surg 2002; 28: 589-592
5. Schulz-Key S, Carlsson JO, Crafoord S. Long term follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction. Acta Ophthalmol 2011; 89: 159-165
6. Tan HS, Mura M, Oberstein L, Heico MB. Safety of vitrectomy for floaters. Am J Ophthalmol 2011; 151: 995-998
7. Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res 2000; 19: 323-344
8. Bishop PN, Holmes DF, Kadler KE, McLeod D, Bos KJ. Age-related changes on the surface of vitreous collagen fibrils. Invest Ophthalmol Vis Sci 2004; 45: 1041-1046
9. Bos KJ, Holmes DF, Meadows RS, Kadler KE, McLeod D, Bishop PN. Collagen fibril organisation in mammalian vitreous by freeze etch/rotary shadowing electron microscopy. Micron 2001; 32: 301-306
10. Le Goff MM, Bishop PN. Adult vitreous structure and postnatal changes. Eye 2008; 22: 1214-1222
11. Balazs EA, Denlinger JL. Aging changes in the vitreousIn: Aging and Human Visual Function. Alan R. Liss Inc.: New York, NY, USA, 1982; 45-57
12. McLeod D, Leaver PK. Trampolines and triangles-the surgical pathology of the vitreous. Trans Ophthal Soc UK 1977; 97: 225-231
13. Foos RY, Wheeler NC. Vitreoretinal juncture. Synchysis senilis and posterior vitreous detachment. Ophthalmology 1982; 89: 1502-1512
14. Snead MP, Snead DR, Richards AJ, Harrison JB, Poulson AV, Morris AH, et al. Clinical, histological and ultrastructural studies of the posterior hyaloid membrane. Eye 2002; 16: 447-453
15. Webb BF, Webb JR, Schroeder MC, North CS. Prevalence of vitreous floaters in a community sample of smartphone users. Int J Ophthalmol 2013; 6(3): 402-405
16. Serpetopoulos CN, Korakitis RA. An optical explanation of the entoptic phenomenon of 'clouds' in posterior vitreous detachment. Ophthalmic Physiol Opt 1998; 18: 446-451
17. Morita H, Funata M, Tokoro T. A clinical study of the development of posterior vitreous detachment in high myopia. Retina 1995; 15: 117-124
18. Schwartz SG, Flynn Jr HW , Fisher YL. Floater scotoma demonstrated on spectral-domain optical coherence tomography and caused by vitreous opacification. Ophthalmic Surg Lasers Imaging Retina 2013; 44(4): 415-418
19. Sebag J. The vitreous: Structure, Function and Pathobiology. Springer-Verlag: New York, NY, USA, 1989; 60-61
20. Wong TY, Foster PJ, Hee J, Ng TP, Tielsch JM, Chew SJ, et al. Prevalence and risk factors for refractive errors in adult Chinese in Singapore. Invest Ophthalmol Vis Sci 2000; 41(9): 2486-2494
21. de Nie KF, Crama N, Tilanus MA, Klevering BJ, Boon CJ. Pars plana vitrectomy for disturbing primary vitreous floaters: clinical outcome and patient satisfaction. Graefes Arch Clin Exp Ophthalmol 2013; 251: 1373-1382
22. Roth M, Trittibach P, Koerner F, Sarra G. Pars plana vitrectomy for idiopathic vitreous floaters. Klin Monatsbl Augenheilkd 2005; 222: 728-732
23. Mason JO 3rd, Neimkin MG, Mason JO 4th, Friedman DA, Feist RM, Thomley ML, et al. Safety, efficacy, and quality of life following sutureless vitrectomy for symptomatic vitreous floaters. Retina 2014; 34(6): 1055-1061
24. Machemer R, Buettner H, Norton EW, Parel JM. Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol 1971; 75: 813-820
25. The SPR Study Group. View 2. The case for primary vitrectomy. Br J Ophthalmol 2003; 87: 784-787
26. Ezra E, Gregor ZJ. Surgery for idiopathic full-thickness macular hole: two-year results of a randomized clinical trial comparing natural history, vitrectomy, and vitrectomy plus autologous serum: Morfields Macular Hole Study Group. Arch Ophthalmol 2004; 122: 224-236
27. De Bustros S, Thompson JT, Michels RG, Rice TA, Glaser BM. Vitrectomy for idiopathic epiretinal membranes causing macular pucker. Br J Ophthalmol 1988; 72: 692-695
28. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study Report 2. Arch Ophthalmol 1985; 103: 1644-1652
29. Wilkinson CP. Safety of vitrectomy for floaters-how safe is safe? Am J Ophthalmol 2011; 151: 919-920
30. Delaney YM, Oyinloye A, Benjamin L. Nd: YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters. Eye 2002; 16: 21-26
31. Stoffelns BM, Vetter J, Keicher A, Mirshahi A. Pars plana vitrectomy for visually disturbing vitreous floaters in pseudophacic eyes. Klin Monbl Augenheilkd 2011; 228(4): 293-297
32. Martínez-Sanz F, Velarde JI, Casuso P, Fernández-Cotero JN. Surgical solution to vitreous floaters visual problem. Arch Soc Esp Oftalmol 2009; 84: 259-262
33. Mura M, Engelbrecht LA, de Smet MD, Papadaki TG, van den Berg TJ, Tan HS. Surgery for floaters. Ophthalmology 2011; 118: 1894-1894
34. Gosse E, Newsom R, Lochhead J. The incidence and distribution of iatrogenic retinal tears in 20-gauge and 23-gauge vitrectomy. Eye 2012; 26: 140-143
35. Covert DJ, Henry CR, Bhatia SK, Croskrey J, Sanchez CR, Han DP. Intraoperative retinal tear formation and postoperative rhegmatogenous retinal detachment in transconjunctival cannulated vitrectomy systems compared with the standard 20-gauge system. Arch Ophthalmol 2012; 130: 186-189
36. Jalil A, Ho WO, Charles S, Dhawahir-Scala F, Patton N. Iatrogenic retinal breaks in 20-G versus 23-G pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 2013; 251: 1463-1467
37. Rizzo S, Belting C, Genovesi-Ebert F, di Bartolo E. Incidence of retinal detachment after small-incision, sutureless pars plana vitrectomy compared with conventional 20-gauge vitrectomy in macular hole and epiretinal membrane surgery. Retina 2010; 30: 1065-1071
38. Rasouli M, Steed SM, Tennant MT, Rudnisky CJ, Hinz BJ, Greve MD, et al. The 1-year incidence of rhegmatogenous retinal detachment post 23-gauge pars plana vitrectomy. Can J Ophthalmol 2012; 47: 262-263
39. Sebag J, Yee KM, Wa CA, Huang LC, Sadun AA. Vitrectomy for floaters: Prospective Efficacy Analyses and Retrospective Safety Profile. Retina 2014; 34(6): 1062
40. Geck U, Pustolla N, Baraki H, Atili A, Feltgen N, Hoerauf H. Posterior vitreous detachment following intravitreal drug injection. Graefes Arch Clin Exp Ophthalmol 2013; 251(7): 1691-1695
41. Henry CR, Schwartz SG, Flynn HW Jr. Endophthalmitis following pars plana vitrectomy for vitreous floaters. Clin Ophthalmol 2014; 8: 1649-1653
42. Park JC, Ramasamy B, Shaw S, Prasad S, Ling RH. A prospective and nationwide study investigating endophthalmitis following pars plana vitrectomy: incidence and risk factors. Br J Ophthalmol 2014; 98(4): 529-533
43. Henry CR, Smiddy WE, Flynn HW Jr. Pars plana vitrectomy for vitreous floaters: is there such a thing as minimally invasive vitreoretinal surgery? Retina 2014; 34(6): 1043-1045
44. Wa C, Sebag J. Safety of vitrectomy for floaters. Am J Ophthalmol 2011; 152(6): 1077
45. Tsai WF, Chen YC, Su CY. Treatment of vitreous floaters with neo-dymium YAG laser. Br J Ophthalmol 1993; 77: 485-488
46. Aron-Rosa D, Greenspan DA. Neodymium: YAG laser vitreolysis. Int Ophthalmol Clin 1985; 25: 125-134
47. Fankhauser F, Kwasniewski SF, van der Zypen E. Vitreolysis with the Q-switched laser. Arch Ophthalmol 1985; 103: 1166-1171
48. Puliafito KA, Wasson PJ, Steinert RF. Neodymium-YAG laser surgery on experimental vitreous membrane. Arch Ophthalmol 1984; 102: 843-847
49. Jampol LM, Goldberg MF, Jednock N. Retinal damage from a Q-switched YAG laser. Am J Ophthalmol 1983; 96: 326-329
50. Jagger JD, Hamilton AM, Polkinghorne P. Q-switched neodymium YAG laser vitreolysis in the therapy of posterior segment disease. Graefes Arch Clin Exp Ophthalmol 1990; 228: 222-225
51. Little HL, Jack RL. Q switched neodymium: YAG laser surgery of the vitreous. Graefes Arch Clin Exp Ophthalmol 1986; 224: 240-246
52. Cowan LA, Khine KT, Chopra V, Fazio DT, Francis BA. Refractory open angle glaucoma after Nd: YAG laser lysis of vitreous floaters. Am J Ophthalmol 2015; 159: 138-143